H-Leu-NHOH · TFA is a leucine-derived amino acid derivative featuring the side chain of leucine attached to an amino acid backbone and converted to a hydroxylamine (-NHOH) functional group at the terminal position, with the molecule present as a trifluoroacetate (TFA) salt. The structure includes an α-amino functionality and a carboxyl group consistent with the leucine framework, while the -NHOH substituent provides an oxime/hydroxylamine-type nucleophilic handle that can participate in chemoselective derivatization and condensation reactions under appropriate conditions. As a labeled or functionalized leucine building block, the compound is used in amino acid chemistry and peptide-related synthesis workflows to introduce a hydroxylamine-bearing leucine motif for subsequent conjugation, linkage formation, or analytical derivatization where controlled side-chain functionality is required.
CAT No: CP26992
CAS No:31982-78-2
Synonyms/Alias:L-Leucyl-Hydroxylamine;L-Leucinehydroxamate;CHEMBL303296;31982-78-2;(2S)-2-amino-N-hydroxy-4-methylpentanamide;4tln;LNO;Ahmpe;Leucinehydroxamate;leucinehydroxamicacid;AC1MIVO9;H-Leu-NHOH.TFA;SCHEMBL4318870;UJJHPFLWSVFLBE-YFKPBYRVSA-N;KUC108817N;KSC-22-148A;ZINC2522572;BDBM50129202;AKOS013307139;DB03308;KB-53298;OR020412;OR257419;(S)-2-amino-N-hydroxy-4-methylpentanamide;FT-0693748
H-Leu-NHOH · TFA is a leucine-derived aminooxy compound provided as a trifluoroacetate salt, featuring the chiral (S)-leucine backbone with a free aminooxy functionality (-NHOH) and a carboxylate protected as a TFA counterion. The molecule's stereogenic center at the α-carbon enables stereochemically defined incorporation into peptide-adjacent linkages and chiral intermediate sequences, while the aminooxy group participates in carbonyl condensation chemistry to form oxime and related C-N linkages under controlled conditions. The trifluoroacetate form modulates basicity and handling, supporting compatibility with peptide chemistry workflows where proton transfer and salt formation can influence coupling and downstream transformations. The combination of an amino acid framework and a reactive aminooxy moiety makes the compound suitable as a chemically defined building block for derivatization, labeling, and synthetic intermediate preparation in both research and applied manufacturing contexts.
1. Aminooxy Peptide Coupling
H-Leu-NHOH · TFA is applied in peptide and peptide-analog construction workflows where aminooxy functionality enables chemoselective oxime-forming bond formation to introduce stable C-N linkages at defined positions. The leucine side chain provides hydrophobic character and stereochemical definition, while the aminooxy group can be used to connect amino acid-derived fragments to carbonyl-bearing partners used in scaffold assembly and conjugation strategies. Trifluoroacetate counterion handling supports controlled reactivity during sequence design, including iterative intermediate generation for protected amino acid synthesis and subsequent coupling steps. Downstream use often involves preparing amino acid-containing conjugates and oxime-linked peptide mimetics that retain the chiral leucine stereocenter for structure-activity relationship studies.
2. Chemical Biology Labeling
H-Leu-NHOH · TFA is used in chemical biology for site-specific labeling strategies that rely on aminooxy-mediated oxime ligation to attach leucine-containing handles to aldehyde or ketone functional groups on biomolecular targets. The amino acid backbone contributes a defined chiral stereocenter and a hydrophobic side chain that can influence solubility and binding behavior of the resulting labeled constructs. The aminooxy (-NHOH) group serves as the reactive pharmacophore for forming C-N linkages while maintaining compatibility with aqueous-compatible derivatization schemes used for probe generation. The trifluoroacetate salt form can facilitate reproducible reactivity in labeling workflows and supports the preparation of analytical standards and biomolecule modification intermediates for downstream detection and characterization.
3. Peptidomimetic SAR Studies
H-Leu-NHOH · TFA is suitable for structure-activity relationship studies in peptidomimetic design where leucine-derived stereochemistry and aminooxy functionality enable systematic variation of linker chemistry. The chiral α-carbon and hydrophobic leucine side chain support the design of analog libraries that probe how stereochemical configuration and side-chain character affect molecular recognition. Aminooxy chemistry supports installation of oxime-derived linkages that can modulate polarity, conformational constraints, and stability relative to alternative amide or ether linkers. Resulting derivatives can serve as fragment-like building blocks for SAR campaigns, enabling rapid generation of analogs for biochemical screening and mechanistic investigations without requiring changes to the leucine stereochemical core.
4. Process Chemistry Intermediate
H-Leu-NHOH · TFA is applied as a chiral amino acid-based intermediate in process chemistry for manufacturing routes that require aminooxy functionality and controlled salt-state handling. The trifluoroacetate counterion provides a defined ionic form that can be leveraged to manage solubility and reproducible dosing of the aminooxy building block in multi-step synthesis toward oxime-linked products. The leucine framework supports downstream conversion into protected or activated derivatives where the aminooxy group can be preserved or transformed according to the targeted coupling sequence. Industrial relevance emerges in the preparation of fine chemical intermediates for conjugate manufacturing, including linker installation steps used to generate oxime-linked materials and chiral amino acid-containing reagents at scale.
5. Analytical Research Standards
H-Leu-NHOH · TFA is utilized in analytical research as a chemically defined amino acid-derived standard for method development involving aminooxy reactivity and oxime formation endpoints. The presence of a single chiral leucine center and a reactive aminooxy group supports unambiguous characterization of derivatized products used in LC-MS, HPLC, and derivatization-based detection workflows. Trifluoroacetate salt identity can aid reproducible ionization behavior and chromatographic consistency when comparing derivatized mixtures across runs. Downstream use includes generating reference oxime derivatives for calibration, verifying derivatization completeness, and supporting quality control of peptide-adjacent conjugation intermediates used in biochemical research and applied chemical manufacturing.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.